BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 18485901)

  • 1. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
    Hoechst B; Ormandy LA; Ballmaier M; Lehner F; Krüger C; Manns MP; Greten TF; Korangy F
    Gastroenterology; 2008 Jul; 135(1):234-43. PubMed ID: 18485901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.
    Höchst B; Schildberg FA; Sauerborn P; Gäbel YA; Gevensleben H; Goltz D; Heukamp LC; Türler A; Ballmaier M; Gieseke F; Müller I; Kalff J; Kurts C; Knolle PA; Diehl L
    J Hepatol; 2013 Sep; 59(3):528-35. PubMed ID: 23665041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD14
    Bernsmeier C; Triantafyllou E; Brenig R; Lebosse FJ; Singanayagam A; Patel VC; Pop OT; Khamri W; Nathwani R; Tidswell R; Weston CJ; Adams DH; Thursz MR; Wendon JA; Antoniades CG
    Gut; 2018 Jun; 67(6):1155-1167. PubMed ID: 28592438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
    Du J; Sun X; Song Y
    Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
    Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
    Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and prognostic significance of CD14 (+) HLA-DR (-/low) myeloid-derived suppressor cells in patients with hepatocellular carcinoma received transarterial radioembolization with Yttrium-90.
    Boral B; Ballı HT; Sözütok S; Pehlivan UA; Aikimbaev K
    Scand J Immunol; 2022 Mar; 95(3):e13132. PubMed ID: 34936119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis.
    Arihara F; Mizukoshi E; Kitahara M; Takata Y; Arai K; Yamashita T; Nakamoto Y; Kaneko S
    Cancer Immunol Immunother; 2013 Aug; 62(8):1421-30. PubMed ID: 23764929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells.
    Centuori SM; Trad M; LaCasse CJ; Alizadeh D; Larmonier CB; Hanke NT; Kartchner J; Janikashvili N; Bonnotte B; Larmonier N; Katsanis E
    J Leukoc Biol; 2012 Nov; 92(5):987-97. PubMed ID: 22891289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.
    Garg A; Spector SA
    J Infect Dis; 2014 Feb; 209(3):441-51. PubMed ID: 23999600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
    Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
    Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency and FOXP3 expression of human CD8
    Zahran AM; Nafady-Hego H; Mansor SG; Abbas WA; Abdel-Malek MO; Mekky MA; Hetta HF
    Hum Immunol; 2019 Jul; 80(7):510-516. PubMed ID: 30904437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality.
    Kalathil S; Lugade AA; Miller A; Iyer R; Thanavala Y
    Cancer Res; 2013 Apr; 73(8):2435-44. PubMed ID: 23423978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
    J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Toyoda M; Takahashi K; Yamamoto T; Masuyama K
    Cancer Sci; 2012 Jun; 103(6):976-83. PubMed ID: 22360618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.
    Poschke I; Mougiakakos D; Hansson J; Masucci GV; Kiessling R
    Cancer Res; 2010 Jun; 70(11):4335-45. PubMed ID: 20484028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
    Ormandy LA; Hillemann T; Wedemeyer H; Manns MP; Greten TF; Korangy F
    Cancer Res; 2005 Mar; 65(6):2457-64. PubMed ID: 15781662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.